IMCC
IM Cannabis Corp.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IL
$1.98
−10.00%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.6x
Market Cap
$1.23M
MomentumView details →
1D Return
−10.00%
YTD Return
−95.08%
RSI (14)
28.2
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.6x
Market Cap
$1.23M
RSI (14)
28.2
MomentumView details →
1D Return
−10.00%
YTD Return
−95.08%
SummaryUpdated Jun 1, 2026
IM Cannabis Corp. (NASDAQ:IMCC) is an Israeli-based medical cannabis company founded in 2016 that has evolved from a multi-market operator to a focused player in the German and Israeli medical cannabis markets. The company went public in May 2020 and is headquartered in Tel Aviv-Yafo, Israel. After initially expanding into Canada, IM Cannabis has strategically refocused its operations on the more promising European and Middle Eastern markets, particularly capitalizing on Germany's cannabis legalization in April 2024.
Similar companies
Latest newsMore news →
IM Cannabis Corp. entered into a letter of intent to sell its European-focused assets to Slil.com Holding Ltd.78d agoIM Cannabis Corp. filed a resale registration statement on Form F-3 with the SEC, registering 17,276,931 common shares for resale.87d agoIM Cannabis Corp. closed a US$225,000 convertible note financing in a private placement with an institutional investor.93d ago